# aphranel® Hosts European Physicians in China for Clinical Exchange

- Link: https://www.thailand-business-news.com/pr-news/aphranel-hosts-european-physicians-in-china-for-clinical-exchange
- Published: 2026-10-30T16:00:00+07:00
- Author: PR Newswire

_Week-Long Programme Under The Norns’ Weave Examines Chinese Clinical Practice and
Its Potential Applications in Europe_

SHANGHAI, Oct. 30, 2026 /PRNewswire/ — aphranel®, the regenerative aesthetics brand
of MOYOM Biotech, has launched a clinical exchange programme bringing European physicians
to China for a week of clinical observation and discussion. Centred on the concept
of "Learning in China, Applying in Europe," the programme offers European physicians
firsthand exposure to Chinese clinical expertise and injection techniques, with 
opportunities to consider how these approaches might inform practice in Europe. 
The initiative forms part of The Norns’ Weave, a global academic programme connecting
physicians across cultures, clinical practices and aesthetic philosophies. Inspired
by the three Norns of Norse mythology, the programme expresses aphranel®’s philosophy,
_The Poetics of Time_, through three pillars: Dialogue, Exchange and Convergence.

Drawing on more than 12 years of research and development, aphranel® has expanded
its international presence following NMPA Class III medical device approval for 
its MagiCCrystal CaHA filler in China in 2025 and EU MDR certification in 2026. 
The biostructurer uses proprietary CaHA microsphere technology to combine immediate
structural support with collagen biostimulation and complete biodegradation. Through
its Train-the-Trainer (TTT) education framework and international academic partnerships,
aphranel® aims to help physicians share clinical knowledge and strengthen evidence-
based practice in regenerative aesthetics worldwide.

Dr. Tiago Guimarães, accompanied by the aphranel® European Medical and Sales Team,
recently visited China for a multi-city clinical immersion programme with aphranel
®-certified Chinese physicians. The delegation visited Yestar Medical Aesthetic 
Hospital and Huamei Zixin Medical Aesthetic Hospital in Guangzhou; Shenzhen Fanyan
Aesthetics and Shenzhen Boai Shuguang Hospital in Shenzhen; REAL Medical Aesthetics
in Shanghai; and Estee Ryan and JollyHue in Hangzhou.

[⌊Physicians from the UK observe clinical injection demonstrations during visits
to aesthetic clinics in China.⌉⌊Physicians from the UK observe clinical injection
demonstrations during visits to aesthetic clinics in China.⌉[
Physicians from the
UK observe clinical injection demonstrations during visits to aesthetic clinics 
in China.

Through facial aesthetic assessments, clinical case discussions and injection demonstrations,
participating physicians exchanged practical insights into individualised treatment
planning and CaHA-based facial biostructuring.

The discussions considered differences in ethnic background, facial anatomy and 
aesthetic preferences across regions, as well as the clinical potential of aphranel
® as a new-generation CaHA biostructurer. Physicians examined its use at different
anatomical depths, including placement onto the periosteum for deep structural support
and injection into more superficial layers to improve soft-tissue quality. These
applications were considered within individualised treatment plans addressing both
facial structure and soft-tissue quality.

The exchange identified shared clinical priorities across different approaches to
treatment: preserving natural facial expression, respecting anatomical diversity
and achieving balanced, personalised aesthetic outcomes. The Norns’ Weave is designed
to give physicians opportunities to compare approaches and learn from one another’s
clinical experience, developing their knowledge of regenerative materials and injection
techniques.

The programme has also included exchanges with medical communities in the Middle
East. At the Saudi Arabian Aesthetic Medicine Scientific Conference (SAAM) in Riyadh,
Chinese aesthetic physicians shared facial assessment and injection approaches with
their Middle Eastern counterparts. Medical professionals from the region subsequently
visited MOYOM Biotech’s Shanghai headquarters, continuing the exchange.

[⌊Chinese physicians demonstrate aphranel® injection techniques to local medical
professionals during a clinical exchange in Saudi Arabia.⌉⌊Chinese physicians demonstrate
aphranel® injection techniques to local medical professionals during a clinical 
exchange in Saudi Arabia.⌉[
Chinese physicians demonstrate aphranel® injection techniques
to local medical professionals during a clinical exchange in Saudi Arabia.

With more than 620 partner aesthetic clinics, over 700 certified physicians and 
more than 200,000 syringes used in China within approximately one year of launch,
aphranel® continues to build its clinical education network. MOYOM Biotech plans
to extend The Norns’ Weave through further European academic exchanges, Expert-to-
Expert (E2E) collaborations and the continued development of clinical evidence.

Through these exchanges, The Norns’ Weave connects physicians in China and other
countries to share clinical experience and examine different approaches to regenerative
aesthetics. The programme also provides a setting for exploring _The Poetics of 
Time_—the relationship between regenerative aesthetics and beauty as it evolves 
over time.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [aphranel® Hosts European Physicians in China for Clinical Exchange ](http://www.prnasia.com/story/archive/5085343_CN85343_0?rand=184833)